🇺🇸 Celecoxib (Celebrex) in United States

18 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Asthenia — 4 reports (22.22%)
  2. Arthropathy — 2 reports (11.11%)
  3. Cellulitis — 2 reports (11.11%)
  4. Diarrhoea — 2 reports (11.11%)
  5. Urinary Tract Infection — 2 reports (11.11%)
  6. Vomiting — 2 reports (11.11%)
  7. Abdominal Discomfort — 1 report (5.56%)
  8. Abscess Limb — 1 report (5.56%)
  9. Anal Abscess — 1 report (5.56%)
  10. Anxiety — 1 report (5.56%)

Source database →

Other Rheumatology / Pain Management approved in United States

Frequently asked questions

Is Celecoxib (Celebrex) approved in United States?

Celecoxib (Celebrex) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Celecoxib (Celebrex) in United States?

National Eye Institute (NEI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.